Oxford Confirms Its Coronavirus Vaccine Works and Is Safe, Says Lancet Medical Journal
The first results from crucial Stage 3 trials show that the vaccine protects against symptomatic disease in 70 percent of cases.
Steve Parson/Getty
Oxford’s coronavirus vaccine looks set to become the third proven to be both safe and effective in preventing COVID-19 infection. The first results from the vaccine’s crucial Phase 3 trials indicate that it’s safe to roll out to the public, according to medical journal The Lancet. The results show that that the vaccine protects against symptomatic disease in 70 percent of cases. The vaccine’s efficacy is rated at 62 percent in people given two full doses, but that rises to 90 in those given a half then a full dose. The results are largely in line with interim results announced last month. Study lead author Prof. Andrew Pollard from the University of Oxford said: “Our findings indicate that our vaccine’s efficacy exceeds the thresholds set by health authorities and may have a potential public-health impact.”
See more of our coverage in your search results.
Got a tip? Send it to The Daily Beast here.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.